One important clinical implication of our findings relates to the role of NUCB1 in enhancing the anti-tumor effects of gemcitabine, a first-line chemotherapy for pancreatic cancer patients (Heinemann, 2001). The gene discussed is NUCB1; the disease is familial pancreatic carcinoma.